がん予防財団は、上院におけるメディケア多発がん早期発見スクリーニング保険法案を支持する500以上の団体を率いている。
ふまたは即時リリース
キラ・マイスター
703-836-1746
kyra.meister@preventcancer.org
ワシントンDC - Today, the U.S. Senate introduced bipartisan legislation that recognizes emerging advances in our nation’s fight against cancer by ensuring Medicare can make a coverage decision for new, innovative tests that could detect multiple types of cancer. The Medicare Multi-Cancer Early Detection Screening Coverage Act will allow older Americans with Medicare the possibility of access to multi-cancer early detection (MCED) tests once they are approved by the Food and Drug Administration (FDA) and shown to have clinical benefit. MCED tests, also called liquid biopsies, are blood-based tests, designed to identify the presence of cancer for more than one cancer at a time.
S. 2085 is sponsored by U.S. Sens. Mike Crapo (R-Idaho), Michael Bennet (D-Colo.), Tim Scott (R-S.C.) and Ben Cardin (D-Md.). This legislation modernizes the Medicare program and creates a benefit category for MCED tests, which allows the Centers for Medicare and Medicaid Services (CMS) to initiate an evidenced-based coverage process for multi-cancer tests upon FDA approval.
On March 30, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act was introduced in the U.S. House of Representatives. H.R. 2407 is sponsored by U.S. Reps. Jodey Arrington (R-Texas), Terri Sewell (D-Ala.), Richard Hudson (R-N.C.) and Raul Ruiz (D-Calif.). S. 2085 is the companion bill that brings us one step closer to enabling older Americans with Medicare to access MCED tests. The Prevent Cancer Foundation appreciates the leadership of Sens. Crapo, Bennet, Scott and Cardin on this legislation to ensure that Medicare beneficiaries, and their health care providers, have access to these transformative new early detection tests.
“Without systems driving us forward to ignite change, existing disparities and the number of cancers found in late stages are likely to remain stagnant,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “We are hopeful that Congress will act swiftly in passing this important legislation.”
Breaking barriers in cancer prevention and early detection is a collective effort, and the Prevent Cancer Foundation is leading the charge. The Foundation is honored to announce that 500+ organizations from every corner of the country have come together to endorse H.R. 2407 and S. 2085. This landmark legislation is a crucial step toward ensuring that older Americans with Medicare have access to these potentially lifesaving tests.
“Science is changing, treatments are improving, but coverage is not keeping up. We need Congress to enable Medicare patients to access the newest lifesaving or life-extending tests and treatments,” said Carole Florman, policy fellow at CancerCare, one of the more than 500 organizations who has signed on to support this legislation.
Read the full letter and view the list of signers. For more information on multi-cancer early detection, visit www.preventcancer.org/early.
###
がん予防財団について®
がん予防財団® は 唯一の米国-ベース 非営利団体 専ら ひたむきな に 癌 予防と早期 検出. 研究、教育を通じて、 アウトリーチ およびアドボカシー, 私たちは、数え切れないほど多くの人々ががんの診断を回避したり、早期にがんを発見して治療を成功させるのを支援してきました。 私たちの原動力は がんが予防できる世界のビジョン 検出可能 そして打ち負かすことができる すべてのために.
財団は、2035年までに癌による死亡者数を40%減らすという課題に取り組むために立ち上がっています。これを達成するために、 私たちは がんを早期に発見し、進歩させるための革新的な技術に$20百万を投資することを約束 マルチがん検診、がん検診とワクチン接種へのアクセスを拡大するために$1000万 医学的に 十分なサービスを受けていないコミュニティを支援し、検査とワクチン接種の選択肢について一般の人々を啓蒙するために$1000万ドルを支出します。
詳細については、 がん予防.